Quantitative Determination of NDMA Impurity in Ranitidine Drug Products – Examples of Actual Samples Analysis by LCMS-8060 with APCI

NDMA impurity in Ranitidine / LCMSTM-9030 Application News Detection and Quantitation of NDMA Impurity in Ranitidine Drug Substances and Products by LC-HRMS on LCMS-9030 Zhe Sun and Zhaoqi Zhan User Benefits  Determination of NDMA in ranitidine API and drug…

Application Note No. 62 Analysis of Pharmaceuticals’ Impurity - Regulations and Analysis for Carcinogenic Substances Dheeraj Handique *a), Nitish Suryawanshi *a), Crystal Yeong *b), Cynthia Lahey *b), Shailendra Rane *a), Deepti Bhandarkar *a), Anant Lohar *a), Gao Jie san *c),…

Application Note Pharma & Biopharma Determination of NDMA Impurity in Ranitidine Using the Agilent 6470 Triple Quadrupole LC/MS Detection of regulated genotoxic impurity from the drug manufacturing process Authors Chander Mani and Saikat Banerjee Agilent Technologies, Inc. Abstract Impurities in…

Vol ISSUE1 SJ20_0081 ISSN 2188-0484 Pharmaceutical Note from the Director Shuzo Maruyama General Manager, Analytical & Measurement Instruments Division The new coronavirus (COVID-19) has now for PCR detection. Preparations are underway become a global pandemic. Shimadzu Corpo- to export these…